Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada
OBJECTIVE: To evaluate the comparative cost of treatment and intermediate outcomes (percentage resistant organisms, days in hospital, etc) among cefepime and alternative parenteral antibiotics used for empiric monotherapy.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1997-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1997/106462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558128626925568 |
|---|---|
| author | Michael T Halpern Ruth E Brown Martine Drolet Sonja V Sorensen Lionel A Mandell |
| author_facet | Michael T Halpern Ruth E Brown Martine Drolet Sonja V Sorensen Lionel A Mandell |
| author_sort | Michael T Halpern |
| collection | DOAJ |
| description | OBJECTIVE: To evaluate the comparative cost of treatment and intermediate outcomes (percentage resistant organisms, days in hospital, etc) among cefepime and alternative parenteral antibiotics used for empiric monotherapy. |
| format | Article |
| id | doaj-art-b96a008a6f1f456a9ee5748b3417576e |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 1997-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-b96a008a6f1f456a9ee5748b3417576e2025-02-03T01:33:14ZengWileyCanadian Journal of Infectious Diseases1180-23321997-01-0181192710.1155/1997/106462Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in CanadaMichael T Halpern0Ruth E Brown1Martine Drolet2Sonja V Sorensen3Lionel A Mandell4MEDTAP International, Bethesda, Maryland, CanadaMEDTAP International, Bethesda, Maryland, CanadaBristol–Myers Squibb, Montreal, Quebec, CanadaMEDTAP International, Bethesda, Maryland, CanadaMEDTAP International, Bethesda, Maryland, CanadaOBJECTIVE: To evaluate the comparative cost of treatment and intermediate outcomes (percentage resistant organisms, days in hospital, etc) among cefepime and alternative parenteral antibiotics used for empiric monotherapy.http://dx.doi.org/10.1155/1997/106462 |
| spellingShingle | Michael T Halpern Ruth E Brown Martine Drolet Sonja V Sorensen Lionel A Mandell Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada Canadian Journal of Infectious Diseases |
| title | Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada |
| title_full | Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada |
| title_fullStr | Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada |
| title_full_unstemmed | Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada |
| title_short | Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada |
| title_sort | decision analysis modelling of costs and outcomes following cefepime monotherapy in canada |
| url | http://dx.doi.org/10.1155/1997/106462 |
| work_keys_str_mv | AT michaelthalpern decisionanalysismodellingofcostsandoutcomesfollowingcefepimemonotherapyincanada AT ruthebrown decisionanalysismodellingofcostsandoutcomesfollowingcefepimemonotherapyincanada AT martinedrolet decisionanalysismodellingofcostsandoutcomesfollowingcefepimemonotherapyincanada AT sonjavsorensen decisionanalysismodellingofcostsandoutcomesfollowingcefepimemonotherapyincanada AT lionelamandell decisionanalysismodellingofcostsandoutcomesfollowingcefepimemonotherapyincanada |